Digital Health Views & Analysis

Views & Analysis

Digital

Mixed reactions among HCPs as lecanemab and donanemab secure...

Last month, the FDA granted approval to Eli Lilly’s donanemab - or Kisunla - for the treatment of Alzheimer’s disease.

Digital

Tech & Trials: What’s all this about AI, then?

Welcome to Tech & Trials – a guided tour to the world of AI and clinical trials.

Digital

apps and telemedicine visual illustration

Driving growth with connected health

Connected health stands at the intersection of healthcare and technology, where innovation is reshaping patient care.

Digital

The fall and rise of digital therapeutics

A digital therapeutic (DTx) is defined as “health software intended to treat or alleviate a disease, disorder, condition, or injury by generating and delivering a medical intervention that

Digital

Changing Faces – Digital and supplier hires from July 2024

Welcome back to Changing Faces for the month of July. Today we’re looking at CROs, CDMOs, suppliers, and tech vendors – the industry around pharma that keeps pharma ticking.

Digital

Ask NAVLIN: The AI chatbot innovation driving a better globa...

Demonstrating EVERSANA’s commitment to innovation, a new artificial intelligence technology aims to improve NAVLIN for both existing and new customers.

Mixed reactions among HCPs as lecanemab and donanemab secure...

Tech & Trials: What’s all this about AI, then?

Driving growth with connected health

The fall and rise of digital therapeutics

Changing Faces – Digital and supplier hires from July 2024

Ask NAVLIN: The AI chatbot innovation driving a better globa...

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

Views & Analysis

Editor's Picks